126 related articles for article (PubMed ID: 19194910)
1. Developing an industrial artemisinic acid fermentation process to support the cost-effective production of antimalarial artemisinin-based combination therapies.
Lenihan JR; Tsuruta H; Diola D; Renninger NS; Regentin R
Biotechnol Prog; 2008; 24(5):1026-32. PubMed ID: 19194910
[TBL] [Abstract][Full Text] [Related]
2. Production of the antimalarial drug precursor artemisinic acid in engineered yeast.
Ro DK; Paradise EM; Ouellet M; Fisher KJ; Newman KL; Ndungu JM; Ho KA; Eachus RA; Ham TS; Kirby J; Chang MC; Withers ST; Shiba Y; Sarpong R; Keasling JD
Nature; 2006 Apr; 440(7086):940-3. PubMed ID: 16612385
[TBL] [Abstract][Full Text] [Related]
3. High-level semi-synthetic production of the potent antimalarial artemisinin.
Paddon CJ; Westfall PJ; Pitera DJ; Benjamin K; Fisher K; McPhee D; Leavell MD; Tai A; Main A; Eng D; Polichuk DR; Teoh KH; Reed DW; Treynor T; Lenihan J; Fleck M; Bajad S; Dang G; Dengrove D; Diola D; Dorin G; Ellens KW; Fickes S; Galazzo J; Gaucher SP; Geistlinger T; Henry R; Hepp M; Horning T; Iqbal T; Jiang H; Kizer L; Lieu B; Melis D; Moss N; Regentin R; Secrest S; Tsuruta H; Vazquez R; Westblade LF; Xu L; Yu M; Zhang Y; Zhao L; Lievense J; Covello PS; Keasling JD; Reiling KK; Renninger NS; Newman JD
Nature; 2013 Apr; 496(7446):528-32. PubMed ID: 23575629
[TBL] [Abstract][Full Text] [Related]
4. Induction of multiple pleiotropic drug resistance genes in yeast engineered to produce an increased level of anti-malarial drug precursor, artemisinic acid.
Ro DK; Ouellet M; Paradise EM; Burd H; Eng D; Paddon CJ; Newman JD; Keasling JD
BMC Biotechnol; 2008 Nov; 8():83. PubMed ID: 18983675
[TBL] [Abstract][Full Text] [Related]
5. Heterologous biosynthesis of artemisinic acid in Saccharomyces cerevisiae.
Li C; Li J; Wang G; Li X
J Appl Microbiol; 2016 Jun; 120(6):1466-78. PubMed ID: 26743771
[TBL] [Abstract][Full Text] [Related]
6. Production of amorphadiene in yeast, and its conversion to dihydroartemisinic acid, precursor to the antimalarial agent artemisinin.
Westfall PJ; Pitera DJ; Lenihan JR; Eng D; Woolard FX; Regentin R; Horning T; Tsuruta H; Melis DJ; Owens A; Fickes S; Diola D; Benjamin KR; Keasling JD; Leavell MD; McPhee DJ; Renninger NS; Newman JD; Paddon CJ
Proc Natl Acad Sci U S A; 2012 Jan; 109(3):E111-8. PubMed ID: 22247290
[TBL] [Abstract][Full Text] [Related]
7. High-level production of amorpha-4,11-diene, a precursor of the antimalarial agent artemisinin, in Escherichia coli.
Tsuruta H; Paddon CJ; Eng D; Lenihan JR; Horning T; Anthony LC; Regentin R; Keasling JD; Renninger NS; Newman JD
PLoS One; 2009; 4(2):e4489. PubMed ID: 19221601
[TBL] [Abstract][Full Text] [Related]
8. Microbially derived artemisinin: a biotechnology solution to the global problem of access to affordable antimalarial drugs.
Hale V; Keasling JD; Renninger N; Diagana TT
Am J Trop Med Hyg; 2007 Dec; 77(6 Suppl):198-202. PubMed ID: 18165493
[TBL] [Abstract][Full Text] [Related]
9. The gal80 Deletion by CRISPR-Cas9 in Engineered Saccharomyces cerevisiae Produces Artemisinic Acid Without Galactose Induction.
Ai L; Guo W; Chen W; Teng Y; Bai L
Curr Microbiol; 2019 Nov; 76(11):1313-1319. PubMed ID: 31392501
[TBL] [Abstract][Full Text] [Related]
10. Engineering yeast for industrial-level production of the antimalarial drug artemisinin.
Smith AB; Chekan JR
Trends Biotechnol; 2023 Mar; 41(3):267-269. PubMed ID: 36528397
[TBL] [Abstract][Full Text] [Related]
11. [Biosynthesis of amorpha-4,11-diene, a precursor of the antimalarial agent artemisinin, in Escherichia coli through introducing mevalonate pathway].
Wu T; Wu S; Yin Q; Dai H; Li S; Dong F; Chen B; Fang H
Sheng Wu Gong Cheng Xue Bao; 2011 Jul; 27(7):1040-8. PubMed ID: 22016988
[TBL] [Abstract][Full Text] [Related]
12. The production of artemisinin precursors in tobacco.
Zhang Y; Nowak G; Reed DW; Covello PS
Plant Biotechnol J; 2011 May; 9(4):445-54. PubMed ID: 20723135
[TBL] [Abstract][Full Text] [Related]
13. Identification of intermediates and enzymes involved in the early steps of artemisinin biosynthesis in Artemisia annua.
Bertea CM; Freije JR; van der Woude H; Verstappen FW; Perk L; Marquez V; De Kraker JW; Posthumus MA; Jansen BJ; de Groot A; Franssen MC; Bouwmeester HJ
Planta Med; 2005 Jan; 71(1):40-7. PubMed ID: 15678372
[TBL] [Abstract][Full Text] [Related]
14. High-cell-density fermentation for ergosterol production by Saccharomyces cerevisiae.
Shang F; Wen S; Wang X; Tan T
J Biosci Bioeng; 2006 Jan; 101(1):38-41. PubMed ID: 16503289
[TBL] [Abstract][Full Text] [Related]
15. Nicotiana benthamiana as a production platform for artemisinin precursors.
van Herpen TW; Cankar K; Nogueira M; Bosch D; Bouwmeester HJ; Beekwilder J
PLoS One; 2010 Dec; 5(12):e14222. PubMed ID: 21151979
[TBL] [Abstract][Full Text] [Related]
16. [
Guo W; Ai L; Hu D; Chen Y; Geng M; Zheng L; Bai L
Sheng Wu Gong Cheng Xue Bao; 2022 Feb; 38(2):737-748. PubMed ID: 35234394
[TBL] [Abstract][Full Text] [Related]
17. Towards a cost effective strategy for cutinase production by a recombinant Saccharomyces cerevisiae: strain physiological aspects.
Ferreira BS; Calado CR; van Keulen F; Fonseca LP; Cabral JM; da Fonseca MM
Appl Microbiol Biotechnol; 2003 Mar; 61(1):69-76. PubMed ID: 12658517
[TBL] [Abstract][Full Text] [Related]
18. Alcoholic fermentation with flocculant Saccharomyces cerevisiae in fed-batch process.
Guidini CZ; Marquez LD; de Almeida Silva H; de Resende MM; Cardoso VL; Ribeiro EJ
Appl Biochem Biotechnol; 2014 Feb; 172(3):1623-38. PubMed ID: 24241971
[TBL] [Abstract][Full Text] [Related]
19. Production of artemisinin by genetically-modified microbes.
Zeng Q; Qiu F; Yuan L
Biotechnol Lett; 2008 Apr; 30(4):581-92. PubMed ID: 18008167
[TBL] [Abstract][Full Text] [Related]
20. Approaches and Recent Developments for the Commercial Production of Semi-synthetic Artemisinin.
Kung SH; Lund S; Murarka A; McPhee D; Paddon CJ
Front Plant Sci; 2018; 9():87. PubMed ID: 29445390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
